- New Clues Explain Why Immunotherapy Fails in Pancreatic Cancer
- Does My Child Have a Language Disorder?
- Journalists Talk Hot Health Topics: Urgent Care Clinics Performing Abortions and Doulas’ Pay
- ASCs’ vendor problem
- Providence’s physician chief on its ‘holistic’ approach to value-based care
- What the Health? From KFF Health News: A New CDC Nominee, Again
- States Update Guardianship Laws To Keep Children of Immigrants Out of Foster Care
- Anesthesia job market faces ‘major disruption’
- Florida system raises $100M for new ED
- North Carolina system names COO
- Mark Cuban wants to bring drug manufacturing to hospitals’ doorsteps — literally
- UCI Health names chief AI officer
- Nevada hospital names CEO
- Saint Luke’s taps president for 2 hospitals
- Dental community mourns dentist killed in murder-suicide
- Mass General Brigham, CVS deal could raise healthcare spending $40M annually: Report
- Ideal Dental opens 1st Oklahoma practice, expands in 2 more states
- PDS Health eyes the next era of medical-dental integration
- Mark Cuban dives into direct contracting
- HCA executive pay by the numbers
- Iris Telehealth offers behavioral health analytics platform
- HHS names chief economist, regulatory leader to address healthcare affordability
- Loma Linda University Health names new president
- The best ASCs for colonoscopy, endoscopy in the South: US News
- Tennessee moves forward with CON repeal
- Dental schools take action to alleviate workforce shortages: 6 updates
- American Medical Group Association partners with Talkiatry to expand psych access
- Trump nominates CDC director
- ChristianaCare, Cardiovascular Physicians of Delaware to open joint venture ASC
- 5 states regulating AI in mental health
- Centerstone debuts $13M youth behavioral health campus in Missouri
- 3 DSOs making headlines
- Maine restricts noncompetes for rural healthcare workers
- Heartland Dental opens Florida office
- The 10 biggest ASC deals of the last 5 years
- Affordability, transparency: A look at large employers' top healthcare concerns
- 10 dental Medicaid updates to know from Q1
- White House eyes ibogaine research expansion
- New Weight Loss Research Questions Need for GLP-1 Drugs
- Trump Names CDC Director Pick
- SocialRx teams up with FQHC in NYC to prescribe arts and culture for chronically ill patients
- FDA To Review Whether To Allow More Access To Certain Peptides
- Rising Colon Cancer Deaths Hit Younger Adults Without Degrees Hardest
- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- Over 80% of PCPs concerned about financial stability over next several years
- Industry Voices—DOJ jumps into 340B cases over state law, raising questions about federal plans for the program
- FDA's accelerated approval pathway needs stronger transparency, evidence standards: ICER
- Most People Would Take A Blood Test For Alzheimer's, Study Says
- This Sexually Transmitted Infection Linked To Heart Attack, Stroke
- How Playtime at Age 2, Especially with Parents, Shapes Teen Fitness Habits
- New Depression Treatment Matches ECT with Less Memory Loss, Study Says
- Memory Problems? Your Salt Intake Could Make Matters Worse, Study Says
- Ultra-Processed Foods Linked To Fatty Muscles, Potential Knee Arthritis
- Your New Therapist: Chatty, Leaky, and Hardly Human
- Teva scores in appeal as court revives $177M verdict against Lilly in migraine patent spat
- Gen AI chatbots continually struggle with differential diagnoses, Mass General Brigham study finds
- Listen: With Little Federal Regulation, States Are Left To Shape the Rules on AI in Health Care
- Fierce Pharma Asia—Astellas’ stem cell therapy rethink; GSK’s bullish ADC plan; Daiichi’s OTC sale
- BIO comes out swinging with 'Fight of Our Lives' campaign for the industry’s 50th birthday
- The future of medical-dental integration is here
- Texas dentist has license suspended
- Efforts grow to limit corporate dental ownership, protect dentist autonomy: 6 updates
- What’s the deal with insurer mental health parity violations?
- Remarks at the Options Market Structure Roundtable
- Wider care gaps predicted as mental health parity rule faces rollback
- Sheppard Pratt gets $16.5M for behavioral health expansion
- Former Deputy Surgeon General Erica Schwartz, M.D., nominated as CDC director
- Verily Health simplifies medical jargon alphabet soup with AI-powered app in new campaign
- 10 trends in behavioral health usage: Report
- Cattywampus: Statement on the CAT Concept Release
- Providers' advantage on out-of-network billing disputes likely to continue: Capstone
- Butterflies and Condors: Remarks at the Options Market Roundtable
- Viatris, Teva kick off separate recalls over dissolution, raw material issues
- Mental health ED visits at Children’s Hospital Colorado jump 20% in April
- Rising ACA Costs Leave Many Unable To Pay for Coverage
- One Lot of Xanax Recalled Nationwide Over Quality Issue, FDA Says
- Cough Drops From Several Brands Being Recalled, FDA Says
- CDC May Get New Leader as Officials Consider Erica Schwartz
- Statement at the Roundtable on Options
- Opening Remarks at the Options Market Structure Roundtable
- APA launches resource library for trusted digital mental health tools
- E-Bikes And E-Scooters A Growing Menace On City Streets, Study Says
- 'Absent or trivial' effects: Anti-amyloid Alzheimer's drugs called into question once again
- RFK Jr. kicks off string of congressional hearings to talk White House budget plan
- This Simple Step Could Improve The Benefits From Your Regular Workouts
- New Alzheimer's Drugs Provide No Meaningful Benefit, Major Evidence Review Concludes
- Air Pollution and Weather Tied to Migraines
- Study Says Stress, Weight And Hormones Alter Timing of Puberty in Girls
- Why Walking Remains Unsteady After Partial Spinal Cord Injury
- Roche to launch another Elevidys study after EU rejection of Duchenne gene therapy
- Lilly answers FDA's call for more Foundayo safety info, plotting diabetes filing in parallel
- New Federal Medicaid Rules Require One Month of Work. Some States Demand More.
- As US Birth Rate Falls, Feds’ Response May Make Pregnancy More Dangerous
- Omnicom brews Olixir from FCB Health, rebranding storied agency after Interpublic takeover
- DiMe-led initiative brings together pharma, virtual providers, digital pharmacies to develop blueprint for DTC pharma models
- UPDATED: Heeding RFK Jr.'s call, FDA reclassifies 12 unapproved peptides ahead of advisory committee meeting
- Carrot launches proprietary AI platform for personalized fertility, family care
- UC Health workers plan open-ended, system-wide strike for May 14
- Baylor Scott & White Health Plan to depart individual market, Medicaid this year
- In industry's latest OTC pivot, Daiichi Sankyo lines up $1.5B consumer health unit sale to beverage giant Suntory
- Wildlife Trade Tied To Higher Risk of Diseases Spreading to Humans
- EPA Delays Decisions on 'Forever Chemicals'
- Yes, This is the Worst Pollen Season Ever — Until Next Year
- GoodRx launches 7.2-mg Wegovy dose for self-pay patients at $399 per month
- Providers back bipartisan bill eliminating Medicare chronic care management cost sharing
- Progyny unveils new fertility benefit option for small, mid-size employers
- New Weight Loss Pill, Foundayo, Gets Approval But FDA Seeks More Safety Data
- Seqster launches new data tool to turn clinical sites into 'research-ready data collection points'
- Gilead widens global Yeztugo access agreement, but MSF says supply is 'not nearly enough'
- Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen
- Behavioral health utilization is up with anxiety disorders leading demand, report finds
- Does Your Child Have A Concussion? These Are The Signs, Review Says
- AI Reveals Negative Labels in Medical Records for Sickle Cell Patients
- 'Food-as-Medicine' Improves Life for Heart Failure Patients
- Silent Heart Rhythm Problem Might Triple Risk Of Heart Failure In Seniors
- Blood Test Predicts Alzheimer's Years Before Symptoms, Brain Changes
- An Infectious Combo Triples Risk Of MS, Study Says
- Astellas manufacturing chief views reliable supply, bridging research as his production 'north star'
- Physician compensation up 3% in 2025, but not all specialties saw raises: Medscape
- Pfizer recruits former Angel Lucy Liu for latest mission against cancer
- Teva launches new online schizophrenia community project
- One man’s journey from gambling addiction to recovery and advocacy
- Rural Nebraska Dialysis Unit Closes Despite the State’s $219M in Rural Health Funding
- Medi-Cal Immigrant Enrollment Is Dropping. Researchers Point to Trump’s Policies.
- Ionis exec shares method to the Madness after 2026 Drug Name Tournament win
- Abridge expands clinical decision support solution with UpToDate partnership, new NEJM, JAMA content tie-ups
- Travere maps course for Filspari's $3B US opportunity after landmark rare disease nod
- Hospitals with more disadvantaged patients fall short on price transparency, study finds
- FDA tells Eli Lilly to round up more safety info on key obesity launch Foundayo
- Meat Consumption Rises as Protein Trend Grows, Experts Warn
- Bill would force payers to apply DTC drug purchases to patient deductibles
- Nuts.com Recalls 10,000+ Pounds of Candy Over Allergy Risk
- Listen to the Latest ‘KFF Health News Minute’
- Keebler Health secures $16M in series A funding for AI-powered risk adjustment platform
- Sam’s Club Recalls Children’s Pajamas Due to Fire Hazard
- Small Talk? It May Be Better Than You Think
- J&J, chasing $100B year, sports immunology ‘dual powerhouse’ of Tremfya and new launch Icotyde
- Long-Term Opioid Prescriptions Fall By About A Quarter
- Gut Bacteria Might Drive Rare Food Allergy in Children, Study Finds
- Stents Can Ease Long-Term Symptoms Of Deep Vein Thrombosis, Trial Shows
- Young Cancer Survivors Face Doubled Risk Of Subsequent New Cancer
- Novo taps OpenAI to deploy AI across R&D, manufacturing and corporate functions
- Pfizer rebuked by FDA for misleading Adcetris ads on Facebook
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- Freedom of Associations
- Interfacing with our Inner Demons: Comments on the Division of Trading and Markets' Statement on Certain User Interfaces
- Staff Statement Regarding Broker-Dealer Registration of Certain User Interfaces Utilized to Prepare Transactions in Crypto Asset Securities
- Statement Regarding Staff No-Action Letter to Bank of England
The National Vaccine Injury Compensation Program (VICP or NVICP) was established by the 1986 National Childhood Vaccine Injury Act (NCVIA) which was a response to concerns about the diphtheria, pertussis, and tetanus (DPT) vaccine. The Office of Special Masters of the U.S. Court of Federal Claims administers a no-fault system for litigating vaccine injury claims - except for the COVID-19 vaccines. People claiming injuries from the COVID-19 vaccines have to file a claim with the Countermeasures Injury Compensation Program (CICP). Both the NVICP and the CICP are part of the Health Resources & Services Administration (HRSA), but the claims outcomes have been quite different:
Lawsuit: COVID Vaccine Injury Claims Diverted to Unconstitutional 'Kangaroo Court'
A war on terror–era program is the only legal avenue for people seeking compensation for a COVID vaccine injury.
By Christian Britschgi | November 21, 2023People injured by the COVID-19 vaccines are suing the federal government, claiming the federal program they're forced to pursue compensation through is an opaque and unconstitutional "kangaroo court" that unjustly rejects almost all claims it receives.
"It has become far more obvious that the program offers nothing close to due process," says Christopher Dreisbach, the legal affairs director for React19, a patient group of the vaccine injured. "There's not [just] one thing about the program that can be tweaked and be fixed."
React19 is one of several plaintiffs challenging the constitutionality of the Countermeasures Injury Compensation Program (CICP). The other plaintiffs are all individuals whose compensation claims were rejected by the CICP, despite many having diagnoses from their doctors that the severe injuries they experienced within a few hours or days of receiving a COVID-19 vaccine were a result of the vaccine.
Their lawsuit was filed in October in the U.S. District Court for the Western District of Louisiana.
The CICP is currently the only avenue through which those with a COVID-19 vaccine injury can seek compensation.
A mix of federal law and pandemic-era emergency declarations bar the vaccine injured from suing vaccine manufacturers in civil court. Those with a COVID-19 vaccine injury are also prohibited from pursuing compensation through the standard Vaccine Injury Compensation Program (VICP)—a decades-old program that approves about 50 percent of injury claims in an expedited civil court–like process.
Each year, the VICP paid out $200 million in compensation and attorneys' fees, all of which are funded by an excise tax on vaccines.
Contrast that with the CICP, which has paid out a total of around $30,000 compensating eight people claiming a COVID-19 vaccine injury.
That's out of 12,358 total COVID-related claims the CICP has received, according to the latest federal data. The vast majority of those claims are still pending review. Of the 1,600 claims that the CICP has decided, roughly 98 percent were rejected.
The lawsuit filed by React19 and other patients argues the CICP's high rejection rate is a product of a flawed design that includes an exceedingly short deadline for filing for compensation and an impossibly high burden of proof for showing an injury was caused by a vaccine.
People must file a CICP claim within one year of vaccination. That compares to the VICP deadline that gives people three years following the onset of vaccine injury symptoms to file a petition.
"Most of us don't know what's wrong with us for over a year if we can ever get a diagnosis," says Dreisbach, who himself suffered a COVID-19 vaccine injury. "So many in our community don't even know the program even exists."
Of the 1,588 claims CICP has rejected, 933 of them have been for missed deadlines.
In order to get compensation through the CICP, claimants must also show "compelling, reliable, valid, medical, and scientific evidence" that their injury was caused by a COVID-19 vaccine.
By comparison, the VICP has a pretty low threshold for proving a vaccine injury. People who suffered one of several listed "table" injuries soon after receiving their vaccine are presumed to have been injured by the vaccine. Those who suffer a nontable injury need only show by a preponderance of the evidence (i.e., that it's more likely than not) that they were injured by a vaccine.
The higher burden of proof claimants must show the CICP is compounded by the fact that less scientific evidence exists about the effects of the recently invented COVID-19 vaccines.
"When you're talking 40,000 to 60,000 in a study, we know pretty well short-term side effects, but we don't have very much of an idea of what the long-term side effects will be," says Katharine Van Tassel, a law professor at Case Western Reserve School of Law who co-authored a book on the Food and Drug Administration.
Van Tassel says that while vaccines are safe, "we did not have very much time to study [COVID] vaccines, so we know the risk of injury was higher."
The CICP's high burden of proof is compounded by the fact that it's also a purely administrative process, with few guaranteed rights for those seeking compensation. Federal bureaucrats review and decide claims on their own. Claimants have no right to a lawyer to argue their case against the government, no right to submit expert evidence, and no right to appeal a rejected claim to any court.
That all contrasts with the quasi-judicial VICP, where petitioners are guaranteed a lawyer who can submit expert evidence on their behalf and a neutral special master (judge) decides cases. People in the VICP can also appeal a rejected petition all the way up to the U.S. Supreme Court. If that doesn't work, they can then sue vaccine makers in civil court.
In addition to all these problems is the fact that the CICP was, prior to COVID, a little-used program that's arguably been swamped by the huge number of claims it's received.
The CICP was first authorized in 2005 by a piece of war-on-terror legislation intended to encourage companies to produce emergency countermeasures to a bioweapons attack or a similar disaster by shielding them from lawsuits.
Prior to the pandemic, it had received only 500 claims and paid out compensation to only 30 people (mostly for swine flu vaccine injuries).
Van Tassel says that the government is within its powers to suspend people's normal right to sue companies for damages, provided that it also provides anyone claiming an injury "a reasonable alternative remedy" to sue for damages.
The CICP's high standard of proof, short filing deadlines, and lack of any real procedural rights all cause it to fall woefully short of being a "reasonable alternative remedy," she says.
The claims in the lawsuit from React19 and other plaintiffs that the CICP violates the Fifth and Seventh Amendments' guarantees of due process and jury trials are on firm ground, she says. "I think this is a very strong lawsuit," she tells Reason.
There are various congressional efforts to help those with COVID-19 vaccine injuries.
Rep. Lloyd Doggett (D–Texas) has introduced two bills that would shift COVID-19 vaccine injury claimants into the VICP and then modernize the VICP process. Another much more modest bill proposed by Sen. Robert Casey (D–Penn.) would extend the deadline for filing COVID-19 vaccine injury claims.
Last year, Sen. Mike Lee (R–Utah) also introduced a bill that would reform the CICP to make it more like the VICP program, with special masters deciding cases in federal claims court.
None of these efforts have made much headway in Congress, much to the frustration of vaccine-injured advocates.
"Our community needed help yesterday. We've been asking Congress to take action for over two years, our hope is that this lawsuit forces their hand," says Dreisbach.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.














